Zivo Bioscience, Inc.
ZIVO· OTC
Filed Mar 25, 2013 · 10-K · 84 days after period end · 0001078782-13-000519
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | $4.05K |
| Net Income | — | -$1.41M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 25, 2013 · 84 d after period end